Sunvozertinib lung cancer treatment hit a milestone as AstraZeneca paid $600M upfront for Zegfrovy, the first oral pill to ...
Survival in the transplant group was also similar to a cohort of non-cancer patients who underwent lung transplantation for ...
Breakthrough research led by scientists in Manchester has identified a new drug combination that could improve outcomes for ...
HER2-mutated non-small-cell lung cancer (NSCLC) is a rare form of lung cancer where the cancer cells have a mutation that makes them grow and divide in an uncontrolled way. You can best understand ...
Researchers have identified a new way to target a previously undruggable form of lung cancer, which has shown promise in ...
By Andrew Silver SHANGHAI, July 14 (Reuters) - Shares in China's Dizal Pharmaceutical rose 20% on Tuesday, after the AstraZeneca spin-off announced that the drugmaker would pay $600 million upfront ...
Lung transplant for stage IV lung cancer achieved 100% one-year survival in 17 NSCLC patients in a landmark JAMA study from ...
Scientists have developed a new method for accurately predicting gene changes that cause lung cancer, without the need for slower, more expensive lab techniques.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results